Document is current
Any future updates will be listed below
-
Authors
Peng, Tao
Liang, Zhanwei
Si, Jihao
Huang, Lu
Ye, Hua
Li, Xiaoqing
Sun, Miao
Xie, Jie
Dai, Xinhua
-
Funding
Funding for this research was provided by:
National Key Research and Development program of China (2022YFF0608402)
Plan for Leading Talents of Science and Technology Innovation (WR2202)
- License Information
-
More Information
Article History
Received: 26 September 2024
Accepted: 27 October 2024
First Online: 5 November 2024
Declarations
:
: This study was approved by the Independent Ethics Committee of the National GCP Center for Anticancer Drugs (NCC2020C-209) and was conducted from April 2020.
: The authors declare no competing interests.
